Showing 18,561 - 18,580 results of 106,247 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((non decrease) OR (point decrease)) ))', query time: 1.53s Refine Results
  1. 18561
  2. 18562
  3. 18563
  4. 18564
  5. 18565

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  6. 18566

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  7. 18567

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  8. 18568

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  9. 18569

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  10. 18570

    Charge Distribution in Cationic Molybdenum Imido Alkylidene <i>N</i>‑Heterocyclic Carbene Complexes: A Combined X‑ray, XAS, XES, DFT, Mössbauer, and Catalysis Approach by Mathis Benedikter (9726148)

    Published 2020
    “…The binding situation in the corresponding cationic complexes Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­(NHC)­(OC­(CF<sub>3</sub>)<sub>3</sub>)<sup>+</sup> B­(Ar<sup>F</sup>)<sub>4</sub><sup>–</sup> (NHC = IMes (<b>1</b>), IMesCl<sub>2</sub> (<b>2</b>), IMesMe<sub>2</sub> (<b>3</b>), and IMesH<sub>2</sub> (<b>4</b>) was compared to that of the analogous neutral Schrock catalyst Mo­(<i>N</i>-2,6-Me<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)­(CHCMe<sub>2</sub>Ph)­((OC­(CF<sub>3</sub>)<sub>3</sub>))<sub>2</sub> (<b>5</b>). Single-crystal X-ray data were used as a starting point for the optimization of the geometries of the catalysts at the PBE0-D3BJ/def2-SVP level of theory; the obtained data were compared to those obtained from X-ray absorption (XAS) and emission spectroscopy (XES). …”
  11. 18571

    HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial by Anita Y.M. Kwan (11868016)

    Published 2022
    “…</p> <p><b>Conclusions:</b> Dulaglutide 1.5 mg treatment was statistically associated with a long-lasting decrease in HbA1c over 72 months, irrespective of baseline duration of diabetes, microvascular disease, and BMI.…”
  12. 18572
  13. 18573

    μCT analysis of organotypic cultured embryonic femurs (E13) in basal and TGF-β3 conditions. by Emma L. Smith (716897)

    Published 2015
    “…<p><i>A</i>, μCT images (whole femur tissue; saggital sections; segmented mineralized bone (green); and cross sectional sections of the central diaphysis region) of the embryonic chick femurs (E13) organotypic cultured in basal and TGF-β3 (5ng/ml and 15ng/ml) for 10 days. …”
  14. 18574

    Supplementary Material for: Decreasing Trend in Incidence of Late Onset Culture Positive Bloodstream Infections but Not Late Onset Meningitis in Preterm Infants <33 Weeks Gestation... by Zhou Q. (4138852)

    Published 2021
    “…<b><i>Conclusions:</i></b> There was a decreasing trend of late onset CPBSI but not late onset meningitis. …”
  15. 18575

    <i>TWIST1</i> knockdown activates senescence in human non-small cell lung cancer cells. by Phuoc T. Tran (86869)

    Published 2012
    “…<p>Three different shRNAs were able to knockdown <i>TWIST1</i> mRNA levels and result in decreased TWIST1 protein in the <i>KRAS</i> mutated non-small cell lung cancer (NSCLC) cell line H460 as shown by (A) qPCR and (B) TWIST1 Western blotting on day 9 after the shRNA infection. …”
  16. 18576

    Muscle differentiation genes are regulated by laminin α5 chain. by Léa Ritié (161318)

    Published 2012
    “…<p>(A) Semi-quantitative RT-PCR experiments were performed on E15.5 control and knockout intestines for genes belonging to the muscle compartment. …”
  17. 18577

    Molecular manipulation of AQP5 altered the MT soluble fraction. by Venkataramana K. Sidhaye (319946)

    Published 2013
    “…<p>A. Transduction of adeno-AQP5 in 16HBE cells led to a significant decrease in soluble tubulin fraction. …”
  18. 18578
  19. 18579
  20. 18580

    Synthesis, Anti-HIV Activity, and Metabolic Stability of New Alkenyldiarylmethane HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Bo-Liang Deng (2046553)

    Published 2005
    “…Their stabilities in rat plasma have also been investigated. Although introducing 5-chloro-2-methoxyphenyl or 3-fluoro-5-trifluoromethylphenyl groups into alkenyldiarylmethanes does not maintain the antiviral potency, the structural modification of alkenyldiarylmethanes with a 3-cyanophenyl substituent can be made without a large decrease in activity. …”